Human immunodeficiency virus, AIDS, and organ transplantation

Transplantation Reviews

Volumn 4, Issue 2, 1990, Pages 93-107

  Feduska, Nicholas J ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0343648501     PISSN: 0955470x     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-470X(11)80008-X     Document Type: Article

References (48)

1. Isolation of a T-lvmphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome
2. A pathogenic retrovirus (HTLV-III) linked to AIDS
3. Frequent detection and isolation of cytopathic retrovirus (HTLV-III) from patients with AIDS and at risk for AIDS
4. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS
5. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections
6. Infection by the retrovirus associated with the acquired immunode-ficiency syndrome
7. Revision of the case definition for acquired immunodeficiency syndrome for national reporting—United States
8. The natural history of human immunodeficiency virus infection
9. Transmission of human immunodeficiency virus (HIV) by transplantation: Clinical aspects and time course analysis of viral antigenemia and antibody production
10. Human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody
11. Observations relating to the incidence of the acquired immune deficiency syndrome and other possibly associated conditions in a large population of renal transplant recipients
12. Investigation of HTLV-3 serology in a renal transplant population
13. Transmission of AIDS virus at renal transplantation
14. Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome
15. HTLV-III infection in kidney transplant recipients
16. Acquired immunodeficiency syndrome in a transplant patient
17. The acquired immunodeficiency syndrome and transplantation
18. The problem of human immunodeficiency virus (HIV) infection and transplantation
19. HTLV-III/LAV infection in kidney and liver transplantation
20. Transplantation in HIV+ patients
21. Transmission of the human immunodeficiency virus
22. Acquired immunodeficiency syndrome associated with blood-product transfusions
23. Risk of human immunodeficiency virus infection from blood donors who later developed the acquired immune deficiency syndrome
24. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody
25. Acute human immunodeficiency virus infection: Antigen detection and seroconversion in immunosuppressed patients
26. HTLV-III/ LAV infection in hemodialysis patients
27. Human immunodeficiency viruses
28. The multifaceted retrovirus
29. Molecular organization of the AIDS retrovirus
30. Long latency precedes overt sero-conversion in sexually transmitted human-immunodeficiency-virus infection
31. Seropositivity for HIV, andthe development of AIDS or AIDS related condition: Three year follow up of the San Francisco General Hospital cohort
32. Temporal relation of antigenemia and loss of antibodies to core antigens to development of clinical disease in HIV infection
33. Progression to AIDS in patients with lymphadenopathy or AIDS-related complex: Reappraisal of risk and predictive factors
34. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men
35. Acquired immune deficiency syndrome (AIDS) is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation
36. Long term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia: Potential clinical importance
37. 1986 update of HIV seroprevalence, seroconverstion, AIDS incidence, and immunology of HIV infection in patients with hemophilia A and B
38. Can we afford the false positive rate?
39. Recovery of human immunodeficiency virus from serum
40. Sensitivity of Western blotting (compared with ELISA and immunofluorescence) during seroconversion after HTLV-III infection
41. HIV antigen testing
42. The transfusion safety study group
43. Human immunodeficiency virus infection in hemodialysis patients
44. Infection with human immunodeficiency virus in the Pittsburgh transplant population: A study of 583 donors and 1043 recipients 1981–1986
45. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial